A Survival Case of ABO-Incompatible Liver Transplantation Complicated With Severe Preoperative Infection and Subsequent Overwhelming Postsplenectomy Infection

Transplantation Proceedings

Volumn 41, Issue 9, 2009, Pages 3941-3944

  Takeda, K ^a   Morioka, D ^a   Kumamoto, T ^a   Matsuo, K ^a   Tanaka, K ^a   Endo, I ^a   Togo, S ^a   Shimada, H ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BAKTAR; CD19 ANTIGEN; CIPROFLOXACIN; CORTICOSTEROID; COTRIMOXAZOLE; HYPERTENSIVE AGENT; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MICAFUNGIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PROSTAGLANDIN E1; RITUXIMAB; TACROLIMUS; UNCLASSIFIED DRUG;

ABO INCOMPATIBILITY LIVER TRANSPLANTATION; ADD ON THERAPY; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; B LYMPHOCYTE; BLOOD FLOW; CASE REPORT; CATHETER INFECTION; CELL COUNT; CLINICAL FEATURE; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DISEASE SEVERITY; ENDOTRACHEAL INTUBATION; EVENING DOSAGE; FUNGUS; GRAFT REJECTION; GRAFT SURVIVAL; HEMODIAFILTRATION; HEPATIC ARTERY; HEPATIC COMA; HEPATITIS B; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; HYPERTENSION; INFECTION; INTENSIVE CARE; JAPANESE; LIVER TRANSPLANTATION; LIVING DONOR; LUNG EDEMA; MALE; MIXED INFECTION; MYCOSIS; OXYGENATION; PLASMAPHERESIS; PNEUMOCYSTIS CARINII; PNEUMOCYSTIS PNEUMONIA; PNEUMONIA; POSTOPERATIVE INFECTION; POSTSPLENECTOMY INFECTION; PREOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECURRENT DISEASE; RESPIRATORY FAILURE; SCORING SYSTEM; SEPSIS; SEPTIC SHOCK; SPLENECTOMY; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; THORAX RADIOGRAPHY; TOTAL PARENTERAL NUTRITION; TREATMENT OUTCOME;

ABO BLOOD-GROUP SYSTEM; ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; BACTERIAL INFECTIONS; BLOOD GROUP INCOMPATIBILITY; HEPATITIS B; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MYCOSES; PNEUMONIA; POSTOPERATIVE COMPLICATIONS; PULMONARY EDEMA; SEPSIS; SPLENECTOMY; TREATMENT OUTCOME;

EID: 71749099596     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.02.094     Document Type: Article

References (12)

1. Morioka D., Togo T., Kumamoto T., et al. Six consecutive cases of successful adult ABO-incompatible living transplantation: A proposal for grading the severity of antibody-mediated resection. Transplantation 85 (2008) 171
2. Tanabe M., Shimazu M., Wakabayashi G., et al. Intraportal infusion therapy as a novel approach to ABO-incompatible liver transplantation. Transplantation 73 (2002) 1959
3. Yoshizawa A., Sakamoto S., Ogawa K., et al. New protocol of immunosuppression for liver transplantation across ABO barrier: the use of rituximab, hepatic artery infusion, and preservation of spleen. Transplant Proc 37 (2005) 1718
4. Okabayashi T., and Hanazaki K. Overwhelming postsplenectomy infection syndrome in adults-A clinically preventable disease. W J Gastroenterol 14 (2008) 176
5. Carsetti R., Rosado M.M., and Wardermann H. Peripheral development of B cells in mouse and man. Immunol Rev 197 (2004) 179
6. Machesky K.K., and Cushing R.D. Overwhelming postsplenectomy infection in a patient with penicillin-resistant streptococcus pneumoniae. Arch Fam Med 7 (1998) 178
7. Hansen K., and Singer D.B. Asplenic-hyposplenic overwhelming sepsis: postsplenectomy sepsis revisited. Pediatr Dev Pathol 4 (2001) 105
8. Usui M., Isaji S., Mizuno S., et al. Experiences and problems pre-operative anti-CD20 monoclonal antibody infusion therapy with splenectomy and plasma exchange for ABO-incompatible living donor liver transplantation. Clin Transpl 21 (2007) 24
9. Grim S.A., Pham T., Thielke J., et al. Infectious complications associated with the use of rituximab for ABO-incompatible and positive cross-match renal transplant recipients. Clin Transpl 21 (2007) 628
10. Takeda K., Morioka D., Matsuo K., et al. A case of successful resection after long-term medical treatment of invasive pulmonary aspergillosis following living donor transplantation. Transplant Proc 39 (2007) 3505
11. Shimazu M., and Kitajima M. Living donor liver transplantation with special reference to ABO-incompatible grafts and small-for-size grafts. World J Surg 28 (2004) 2
12. Egawa H., Ohmori K., Haga H., et al. B-cell surface marker analysis for improvement of rituximab prophylaxis in ABO-incompatible adult living donor liver transplantation. Liver Transpl 13 (2007) 579